Edwards Lifesciences Corp
EW- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001099800
In the last 90 days, Edwards Lifesciences Corp insiders filed 0 open-market purchases and 10 sales; 1,345 institutions reported holding it in 13F filings for Q2 2026, worth $47.2B in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Edwards Lifesciences Corp changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 1,257 | 25 | 1,239 | +7 |
| Shares | 508.9M | 1.72M | 514.7M | +7.56M (+1.5%) |
| Value | $42.1B | $142.6M | $37.9B | −$4.01B (−9.6%) |
25 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (143)
Institutions that held Edwards Lifesciences Corp at the end of Q4 2022 but not at the end of Q3 2022.
Showing the largest 100 of 143 by value.
Sold out (136)
Institutions that held Edwards Lifesciences Corp at the end of Q3 2022 and filed for Q4 2022 without it.
Showing the largest 100 of 136 by value.
Not filed for Q4 2022 yet (25)
Institutions that held Edwards Lifesciences Corp at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.